Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alei Feng
YAP1 Amplification as a Prognostic Factor of Definitive Chemoradiotherapy in Nonsurgical Esophageal Squamous Cell Carcinoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
World Journal of Surgical Oncology
Surgery
Oncology
Lymph Node Enlargement After Definitive Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Value and Application of Trimodality Therapy or Definitive Concurrent Chemoradiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
Cancer
Cancer Research
Oncology
The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma After Concurrent Chemoradiotherapy
Cancer Research and Treatment
Cancer Research
Oncology
SOX2 Antagonizes WWC1 to Drive YAP1 Activation in Esophageal Squamous Cell Carcinoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Prognostic Significance of FAM3C in Esophageal Squamous Cell Carcinoma
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis
PLoS ONE
Multidisciplinary
BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated With Cisplatin- Or Docetaxel-Based Chemotherapy/Chemoradiotherapy
PLoS ONE
Multidisciplinary
The Prognostic Value of B7-H6 in Esophageal Squamous Cell Carcinoma
Scientific Reports
Multidisciplinary
